Aurinia Pharmaceuticals AUPH Enterprise value

Enterprise value at other companies

Rogers CorporationROG

$2.77B+141%

Vera TherapeuticsVERA

$2.83B+85.0%

ANI PharmaceuticalsANIP

$1.82B+17.9%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

Theravance BiopharmaTBPH

$588.13M+55.1%

Opko HealthOPK

$1.18B+9.8%

FAQ

What is Aurinia Pharmaceuticals's enterprise value?

Aurinia Pharmaceuticals (AUPH) reported enterprise value of $2.08B in Q2 2026.

How has Aurinia Pharmaceuticals's enterprise value changed year-over-year?

Aurinia Pharmaceuticals's enterprise value increased by 83.9% year-over-year, from $1.13B to $2.08B.

What is the long-term trend for Aurinia Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's enterprise value has grown at a 4.3% compound annual growth rate (CAGR), from $1.71B to $2.11B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.